CRISPR Therapeutics AG - NAMEN AKT (CRSP)

Q3 2024 13F Holders as of 9/30/2024

Type / Class
Equity / NAMEN AKT
Number of holders
152
Total Shares
9.49M
Shares change
-699K
Total reported value, excl. options
$446M
Value change
-$34.8M
Put/Call ratio
0
Number of buys
46
Number of sells
-77
Price
$46.98
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.